After hitting a low of HK$60.6 on October 9, shares of GPIXEL (ASX: 03277) have moved closer to their all-time low of HK$57.05, a sharp contrast to the company's stellar performance at the time of its listing.
On April 17, 2026, GPIXEL (ASX: 03277) successfully listed on the Hong Kong stock exchange at HK$39.88 per share. It surged 75.53% on its first day of trading, then its share price fluctuated upward, reaching an all-time high of HK$116.642 on May 26, one month later, up 192.48% from the IPO price, nearly tripling, with its total market capitalization once approaching HK$52 billion.
But since then, GPIXEL's share price continued to fluctuate and decline over two months, hitting an all-time low of HK$57.05 on July 29, a pullback of more than 51% from the high, and its gain from the IPO price also sharply fell back to 43.05%. After hitting its all-time low, GPIXEL rebounded for more than a month, with the share price slowly rising to HK$96.
But since September 7, GPIXEL has once again entered a slow decline channel, hitting a low of HK$60.60 on October 9, less than 6% away from its all-time low of HK$57.05, with its total market capitalization having fallen back to around HK$28 billion.
The recent continued weakness in GPIXEL's share price may be related to the upcoming unlock of restricted shares. GPIXEL will have 32.6452 million restricted shares officially unlocked on October 17, representing approximately 50% of the global offering and 7.3% of the current total share capital of approximately 445 million shares.
The unlock of more than 30 million restricted shares is undoubtedly an important test of GPIXEL's liquidity, but the more critical question is whether, as the share price continues to weaken with the arrival of the restricted share unlock, this could become a "golden pit" investment opportunity?
Six-Month Trading Decoded: Four Drivers of the Surge and Three Pressures Behind the Pullback
Looking back at GPIXEL's impressive performance of nearly doubling its share price within just over a month after listing, this was the result of multiple factors working together: "solid earnings + domestic substitution narrative + surging market sentiment + obvious thin-float characteristics."
From an earnings perspective, as "the first Hong Kong-listed high-performance CMOS image sensor company," GPIXEL has achieved sustained rapid growth. According to its prospectus, from 2023 to 2025, the company's revenue was approximately RMB 605 million, RMB 673 million, and RMB 857 million, respectively, with a compound annual revenue growth rate of 19.02%; adjusted net profit for the same period was RMB 222 million, RMB 249 million, and RMB 369 million, respectively, with a compound annual growth rate of 28.84%. This is a solid earnings record of continuous revenue growth and accelerating profit release.
On this foundation, GPIXEL's domestic substitution narrative highlights its scarcity. The core of its products lies in differentiated import substitution in the high-end CMOS image sensor field. The company avoids red-ocean consumer markets such as mobile phones and focuses on high-end application scenarios including industrial machine vision, semiconductor inspection, astronomical research, and medical endoscopy. This niche segment was previously monopolized for a long time by international giants such as Sony, ON Semiconductor, and Teledyne, with high technical barriers and supply chain access restrictions.
With breakthroughs in core technologies such as global shutter, backside illumination (BSI), and low-noise readout, GPIXEL's product performance has achieved the capability to compete directly with top-tier international players. At the same time, as a local supplier, it has significant advantages in customized response speed, delivery stability, and localized services. Currently, the company has established itself as a leader among domestic industrial and scientific imaging CIS manufacturers, ranking firmly in the global top three by market share. As downstream equipment manufacturers accelerate domestic verification, the company is gradually achieving stock substitution for overseas competitors and entering the supply chains of overseas professional camera manufacturers.
Solid earnings combined with the certain trend of domestic substitution translated into strong capital enthusiasm for GPIXEL, which was clearly reflected during the IPO stage. According to the prospectus, GPIXEL offered a total of 65.2942 million H shares in its IPO (before exercise of the over-allotment option), of which 6.5295 million H shares were offered publicly, accounting for approximately 10%, with 1,138.21 times oversubscription; and 58.7647 million H shares were placed internationally, accounting for approximately 90%, with 22.69 times oversubscription. Clearly, GPIXEL attracted strong demand from both retail and institutional investors.
The obvious thin-float characteristic was the key support for GPIXEL's nearly 2x cumulative gain at the time of listing. GPIXEL's offering of 65.2942 million H shares represented approximately 15% of the company's total share capital of 435 million shares (before exercise of the over-allotment option). However, it is worth noting that 55.56% of the shares in the international placement were locked up by cornerstone investors, meaning the actually tradable shares after listing were approximately 32.649 million H shares, representing approximately 7.5% of total share capital (before exercise of the over-allotment option). Based on the IPO price of HK$39.88, the market value corresponding to this actually tradable portion was approximately HK$1.3 billion, which can be seen as a "typical small-cap recent listing."
Driven by the above four factors together, GPIXEL closed up more than 70% on its first day of trading, and then fluctuated upward over the following month, with a maximum cumulative gain of nearly 2x. But after rising to the historical high of HK$116.642, the share price entered a deep correction channel, with a maximum pullback of more than 50% from the high. Behind this sharp correction was also the resonance of multiple factors.
First, after the share price doubled in a short period, the valuation rose to a relatively high level, and value regression became the internal driving force behind the share price change. Calculated at the highest price of HK$116.642 per share, after the over-allotment option was exercised, the company's total shares rose to approximately 445 million, and its total market capitalization soared to approximately HK$52 billion, corresponding to a static PE of as high as 128 times for 2025.
Second, the listing and circulation of over-allotment shares further amplified market selling pressure. On May 8, the overall coordinator, on behalf of the international underwriters, fully exercised the over-allotment option at HK$39.88 per share, involving 9.7941 million H shares, representing 15% of the initial global offering shares. This portion of shares officially began trading on May 13. Compared with the secondary market's highest share price of more than HK$116, the cost price of only HK$39.88 meant huge unrealized gains for this portion of shares, constituting significant profit-taking pressure.
In addition, the upcoming unlock of cornerstone restricted shares further suppressed the company's share price performance. Thin-float recent listings naturally have high volatility characteristics of "easy to rise, easy to fall": during an upward cycle, marginal capital can easily push the share price to overshoot; once facing a supply shock, the limited absorbing capacity amplifies the destructiveness of selling pressure. The 30 cornerstone investors introduced by GPIXEL this time collectively subscribed to 32.6452 million H shares, accounting for 7.33% of total share capital after the over-allotment, a not insignificant size.
More critically, these cornerstone investors are mainly financial investment institutions with relatively dispersed shareholding structures. With the share price still showing considerable unrealized gains relative to the IPO price, institutions have a strong desire to cash out. This "low-cost, dispersed, financially oriented" shareholding structure makes pre-unlock reduction expectations a "sword of Damocles" hanging over the share price, continuously suppressing market bullish sentiment.
Accelerating Earnings Explosion in H1 2026, Strong Certainty for Future Growth
From the detailed review of GPIXEL's share price changes above, it is not difficult to see that the sentiment pressure brought by the restricted share unlock has actually been reflected in the share price to some extent, and the negative news has been realized to a certain degree. But if subsequent cornerstone investors cash out their unrealized gains and exit, causing the share price to continue declining, then this could become a good opportunity for long-term investors to position in GPIXEL.
The logic supporting this conclusion lies in the company's interim financial report showing an accelerating earnings explosion in the first half of 2026. Data shows that GPIXEL's revenue in the first half of 2026 was RMB 641 million, up 78.4% year-on-year; adjusted net profit was approximately RMB 285 million, up 127.2% year-on-year; and net profit attributable to shareholders was approximately RMB 250 million, up 197.2% year-on-year. Compared with past earnings growth rates, whether in revenue or profit, GPIXEL's explosive momentum has become very clear.
Specifically on the revenue side, GPIXEL's total revenue growth was mainly driven by the strong performance of CMOS image sensors. During the reporting period, revenue from this business surged 83.2% year-on-year to RMB 635 million, with its proportion of total revenue rising to 99.1%. Among this, revenue from area array sensors, line scan sensors, and other components all achieved substantial growth, driven by robust demand from downstream industrial imaging applications such as high-end industrial inspection, lithium battery inspection, and printed circuit board inspection, with sales volume increasing from 26,400 units in the same period of 2025 to 54,800 units.
Alongside revenue growth, GPIXEL's gross margin rose by more than 6 percentage points from 62.2% in the same period of 2025 to 68.7%, mainly due to continuous improvement in product mix, with an increased proportion of high-gross-margin products applied in high-end inspection fields (including high-end industrial inspection, lithium battery inspection, etc.), which drove gross profit to surge 97.2% to RMB 441 million during the period.
On this basis, effective control of the three major expenses further amplified profit elasticity. In the first half of 2025, GPIXEL's three major expenses accounted for 37.17% of revenue, which fell to 23.82% during the reporting period. The absolute value of the three major expenses rose only modestly by 14.3% with business expansion, far below revenue growth, indicating that economies of scale significantly diluted the expense ratio, which is the key reason why GPIXEL's profit significantly outperformed revenue growth.
Cash flow and the balance sheet make the interim report quality even more solid. During the reporting period, GPIXEL's net operating cash flow was RMB 325 million, accounting for approximately 50.7% of revenue; free cash flow was approximately RMB 261 million; and cash and cash equivalents, restricted funds, and time deposits at period end totaled approximately RMB 3.802 billion, with no interest-bearing borrowings. Current assets accounted for a high proportion, with a current ratio of approximately 8.46, and the debt-to-asset ratio was only 13.27%, meaning the company's future expansion of R&D, construction of centers, and deployment of overseas sales networks basically does not depend on external leverage.
Another forward-looking indicator is contract liabilities for customized sensors of RMB 205.9 million. Although customized revenue in the interim report was only RMB 5.8 million, contract liabilities represent received/receivable customer customization payments that will convert to revenue over the next 1-2 years, forming order visibility for professional imaging, scientific instruments, and special industrial projects.
Standing at the current point and looking to the future, GPIXEL's sustained rapid growth is expected to continue. First, industrial imaging, as the ballast business with the highest certainty over the next 2-3 years, will benefit from the "machine eye replacement" wave brought by domestic manufacturing precision upgrades, extending from the most directly scaling high-end industrial inspection, lithium battery inspection, and PCB inspection to factory automation, 3D imaging, and robot vision. Currently, the global industrial imaging CIS market is expected to expand at a compound annual growth rate of more than 20%, and GPIXEL ranks third globally with a 15.2% share. It will benefit from the industry's continued development, and as the proportion of high-end large-format area arrays, TDI line scans, global shutter, and other products increases, volume growth and structural optimization will simultaneously push up unit prices and gross margins.
While the ballast business steadily scales, semiconductor inspection constitutes the "second curve" with the highest value and greatest elasticity. GPIXEL has already introduced its GL and GIR series into the semiconductor inspection segment. This field has far higher requirements for CIS pixels, noise, frame rate, and reliability than ordinary industrial scenarios. Although the verification cycle is long, once it enters equipment supply chains, it forms extremely strong stickiness, and both per-chip value and gross margin rise significantly, making it the scarcest position in domestic substitution.
From a longer-term perspective, professional imaging, medical imaging, and overseas expansion together form the long-cycle space foundation for GPIXEL. In professional imaging, GPIXEL announced in April 2026 a strategic cooperation with Leica, under which the two parties will jointly customize high-performance CMOS for next-generation Leica cameras, covering the entire chain from chip verification and image tuning to mass production preparation. This means GPIXEL has obtained high-end optical brand endorsement and systematic upgrades in process tuning capability, laying the foundation for subsequent replication to other professional imaging customers.
In the medical imaging field, the CIS market is expected to grow considerably in the coming years. GPIXEL's GXS series targets scenarios such as disposable medical endoscopes, with high per-unit value and strong customer stickiness. Once verified, it is expected to see rapid scale-up. Overseas, first-half overseas revenue reached RMB 130 million, accounting for more than 20%, with products covering more than 30 countries and regions and a direct sales ratio of as high as 94.7%. After the IPO, approximately 10% of proceeds will be used to deepen operating networks in Japan, Belgium, and other locations, promoting the transition from "product export" to "localized customer binding," which will accelerate the company's overseas expansion.
Given the high certainty of its growth logic, the share price adjustment brought by the restricted share unlock is essentially a short-term disturbance at the sentiment and trading level, and does not shake the company's long-term value anchor. If GPIXEL's market capitalization subsequently falls significantly below its intrinsic value due to cornerstone investors' exit, such an oversold condition would instead open a window of substantial excess returns for long-term investors.